Description Nomi® is a medication containing the active ingredient Zolmitriptan 2.5 mg, produced by Square Pharmaceuticals Limited. It is primarily used for the acute treatment of migraine headaches, with or without aura, in adults.

Benefits Nomi® offers rapid relief from migraine headaches by narrowing the blood vessels in the brain, thereby reducing the symptoms and preventing the attack from worsening. It is an effective treatment option for managing acute migraine attacks.

Ingredients The active ingredient in Nomi® is Zolmitriptan 2.5 mg.

Uses and Doses Nomi® is indicated for the acute treatment of migraine with or without aura. The recommended starting dose is 2.5 mg, with a maximum single dose of 5 mg. If the migraine does not resolve within 2 hours or returns, a second dose may be taken after at least 2 hours. The maximum daily dose is 10 mg in any 24 hours.

Side Effects Common side effects include dizziness, dry mouth, nausea, sensation of heaviness, warmth, tightness, cold sensation, drowsiness, fatigue, and peripheral neuropathy (tingling and numbness of feet and hands).

How to Use Take Nomi® as directed by your doctor. Do not handle the strips/film with wet hands. Place it in your mouth without swallowing. It can be taken with or without food, but it is recommended to take it at a fixed time.

Pregnancy & Lactation Nomi® is classified as Pregnancy Category C. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is unknown whether Zolmitriptan is excreted in human milk. A decision should be made to either discontinue nursing or the drug, considering its importance to the mother.

Precautions and Warnings There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, following administration. Sensations of tightness, pain, and pressure in the chest, throat, neck, and jaw may occur. Patients should monitor their blood pressure and avoid driving or operating machinery until they know how the medication affects them.

Safety Information Nomi® should be protected from light and moisture and stored below 30°C. Keep it out of the reach of children. It requires a prescription for use.

Indications Nomi® is indicated for the acute treatment of migraine with or without aura in adults.

Pharmacology Zolmitriptan works by constricting blood vessels and inhibiting the release of pro-inflammatory neuropeptides in the brain, which reduces migraine symptoms.

Therapeutic Class Nomi® belongs to the therapeutic class of 5-HT Agonists.

Storage Conditions Store below 30°C, protected from light and moisture. Keep out of reach of children.

3 FAQ

1. What is Nomi® used for? Nomi® is used for the acute treatment of migraine headaches with or without aura in adults.
2. What are the common side effects of Nomi®? Common side effects include dizziness, dry mouth, nausea, heaviness, warmth, tightness, cold sensation, drowsiness, fatigue, and peripheral neuropathy.
3. How should I take Nomi®? Take Nomi® as directed by your doctor, with or without food. Place the film in your mouth without swallowing, and avoid handling the strips with wet hands.

Disclaimer The information provided herein is for informational purposes only and not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified health provider with any questions regarding a medical condition.

Keywords: Nomi, Zolmitriptan, migraine treatment, Square Pharmaceuticals, headache relief, acute migraine, 2.5 mg tablets, prescription medication, migraine symptoms, 5-HT agonists, migraine medication, quick migraine relief, migraine aura, cranial vasodilation, sensory neuropeptides, serotonin agonist, blood vessel constriction, pro-inflammatory neuropeptides, migraine attack, pharmaceutical product.